These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37576912)

  • 1. Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without.
    Yu B; Hu X; Liu J; Nie Z; Ren Luo Bu C; Li G; Zhou Y; Dong H
    Int J Gen Med; 2023; 16():3383-3391. PubMed ID: 37576912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.
    Liu C; Xu MX; He YM; Zhao X; Du XJ; Yang XJ
    Acta Diabetol; 2017 May; 54(5):443-453. PubMed ID: 28132096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study.
    Zhao X; Sun D; Xu RX; Guo YL; Zhu CG; Wu NQ; Zhang Y; Li S; Gao Y; Liu G; Dong Q; Li JJ
    Biomarkers; 2018 Nov; 23(7):647-653. PubMed ID: 29730953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.
    Hao Y; Yang Y; Wang Y; Li J
    Curr Med Res Opin; 2022 Oct; 38(10):1663-1672. PubMed ID: 35575139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) as a Marker for Predicting the Presence and Severity of Coronary Artery Disease in Untreated Chinese Patients Undergoing Coronary Angiography.
    Sun D; Zhao X; Li S; Zhang Y; Wu NQ; Zhu CG; Guo YL; Gao Y; Qing P; Liu G; Dong Q; Li JJ
    Biomed Environ Sci; 2018 Apr; 31(4):253-260. PubMed ID: 29773088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging).
    Solfrizzi V; Panza F; Colacicco AM; Capurso C; D'Introno A; Torres F; Baldassarre G; Capurso A
    Am J Cardiol; 2002 Apr; 89(7):825-9. PubMed ID: 11909567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Nakamura H; Kataoka Y; Nicholls SJ; Puri R; Kitahara S; Murai K; Sawada K; Matama H; Iwai T; Honda S; Fujino M; Takagi K; Yoneda S; Otsuka F; Nishihira K; Asaumi Y; Tsujita K; Noguchi T
    Atherosclerosis; 2022 May; 349():183-189. PubMed ID: 35450750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients.
    Yao Y; Liu J; Wang B; Zhou Z; Lu X; Huang Z; Deng J; Yang Y; Tan N; Chen S; Chen J; Liu Y
    Front Cardiovasc Med; 2021; 8():817442. PubMed ID: 35097030
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels.
    Zhu L; Zheng J; Gao B; Jin X; He Y; Zhou L; Huang J
    BMC Cardiovasc Disord; 2022 Apr; 22(1):171. PubMed ID: 35428179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between lipoprotein(a) and coronary artery disease].
    Wang G; Li YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):618-20. PubMed ID: 21055285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Lipoprotein(a) and Obstructive Coronary Artery Disease and High-Risk Plaque: Insights From the PROMISE Trial.
    O'Toole T; Shah NP; Giamberardino SN; Kwee LC; Voora D; McGarrah RW; Ferencik M; Lu MT; Kraus WE; Foldyna B; Douglas PS; Shah SH; Pagidipati NJ
    Am J Cardiol; 2024 Nov; 231():40-47. PubMed ID: 39245334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rs10865710 polymorphism in PPARG promoter is associated with the severity of type 2 diabetes mellitus and coronary artery disease in a Chinese population.
    Song Y; Raheel TM; Jia A; Dai G; Liu L; Long X; He C
    Postgrad Med J; 2022 Oct; 98(1164):778-787. PubMed ID: 37062988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years.
    Chen Y; Fu Y; Wang S; Chen P; Pei Y; Zhang J; Zhang R; Niu G; Gu F; Li X
    Cardiovasc Diabetol; 2022 Nov; 21(1):252. PubMed ID: 36397150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
    Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
    Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.